Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05880368 · ClinicalTrials.gov registry record · NA
Partnership in Resilience for Medication Safety (PROMIS)
A NA study of Patient Engagement and Patient Empowerment, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 405
- Enrollment target
- 2
- Study locations
NCT05880368 is a NA study of Patient Engagement and Patient Empowerment that has completed, run by The University of Texas at Arlington. The registered enrollment target is 405 participants, above the 322-participant average among 6 other Patient Engagement trials with a reported enrollment target (26% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT05880368, a NA study of Patient Engagement and Patient Empowerment, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 405 participants
- Enrollment target
- 2
- Study locations
Study Summary
The trial is to assess the impact of two patient partnership tools: (1) a one-page 'visit prep guide' given to relevant patients by clinic staff before seeing the provider, with the intention to improve communication and shared decision-making; and (2) a series of short educational videos that clinic staff can encourage patients to watch.
Conditions Studied
Interventions
- OTHER Patient partnership tools
Study Locations (2)
Texas
- Texas Health Care - Fort Worth
- John Peter Smith Health - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2023-06-26 |
| Est. Completion | 2025-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05880368
The ClinicalTrials.gov registry entry for NCT05880368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 405 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 322-participant average among 6 other Patient Engagement trials with a reported enrollment target (26% higher). The listed sponsor is The University of Texas at Arlington, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Patient Engagement appearing as the primary indexed condition, and to 1 intervention - of which Patient partnership tools is the first listed.
NCT05880368 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05880368 about?
NCT05880368 is a clinical study titled "Partnership in Resilience for Medication Safety (PROMIS)". The trial is to assess the impact of two patient partnership tools: (1) a one-page 'visit prep guide' given to relevant patients by clinic staff before seeing the provider, with the intention to improve communication and shared decision-making; and (2) a series of short educational videos that clini...
What is the current status of trial NCT05880368?
This trial is currently completed. It is a NA study. The enrollment target is 405 participants. The study started on 2023-06-26. Estimated completion is 2025-07-30.
What conditions does trial NCT05880368 study?
This clinical trial studies the following conditions: Patient Engagement, Patient Empowerment, Patient Activation.
What interventions are being tested in trial NCT05880368?
The interventions under investigation include: Patient partnership tools (OTHER).
Who is sponsoring clinical trial NCT05880368?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05880368 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Engagement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Melanated Group Midwifery Care (MGMC)
RECRUITING · NA
-
Virtual and Video Counseling Versus In-Office Counseling for Laparoscopic Hysterectomy
ACTIVE NOT RECRUITING · NA
-
Self-Management and Glycemic Control in Adult Haitian Immigrants With Type 2 Diabetes
ACTIVE NOT RECRUITING · NA
-
Evaluating the Impact of a Supportive Care Program
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.